On Monday, July 29, the next meeting of the Transparency Council.
The agenda includes:
1 Prepare an opinion on the inclusion in reimbursement of drugs containing the active substance rituximab in the indication resulting from changes in the provisions of the drug program.
2 Prepare an opinion on the inclusion in reimbursement of drugs containing the active substa...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
